Norges Bank’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Norges Bank’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-158,900	Closed	-$5.37M	–	2390
2021 Q2	$5.37M	Sell	158,900 -55,100	-26%	-$1.4M	﹤0.01%	1895
2021 Q1	$5M	Buy	+214,000	New	+$6.48M	﹤0.01%	1910

Norges Bank's CNST Position: Q3 2021 in Review

Norges Bank sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 158,900 shares — an estimated $5.37M sold.

Norges Bank first reported a position in CNST in Q1 2021 and held it in 2 quarters. The position peaked at $5.37M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Norges Bank reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Norges Bank sold 158,900 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $5.37M.
Norges Bank first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2021 and held it in 2 quarters.
Norges Bank's Constellation Pharmaceuticals, Inc. position peaked at $5.37M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.